← back to search

Yongcheng Song

Baylor College of Medicine · US
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Epigenetics and DNA Methylation, Glioma Diagnosis and Treatment, Cancer-related gene regulation, and Histone Deacetylase Inhibitors Research.
h-index
46
citations
6,523
works
155
NIH funding
primary concept
email

Recent publications

Synthesis, Structure-Activity Relationships, and Antitumor Activities of Quinoxiline-Containing Inhibitors of the Protein-Protein Interactions between Transcription Coactivator AF9/ENL and DOT1L/AF4.
2025cited by 2position: contributordoi
Targeting the S1' Pocket of SARS-CoV‑2 Papain-Like Protease Yields Highly Potent Inhibitors.
2025cited by 0position: contributordoi
Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition.
2024cited by 7position: contributordoi
Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease.
2024cited by 5position: contributordoi
Quinazolinone Compounds Have Potent Antiviral Activity against Zika and Dengue Virus.
2023cited by 17position: contributordoi
In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus
Acta Pharmaceutica Sinica B 2021cited by 30position: middledoi
Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
2021cited by 27position: contributordoi
Acetylation of histone H3K27 signals the transcriptional elongation for estrogen receptor alpha
Communications Biology 2020cited by 48position: middledoi
Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP.
2020cited by 22position: contributordoi
Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease
Journal of the American Chemical Society 2019cited by 118position: lastdoi
Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease.
2019cited by 100position: contributordoi
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives
Journal of Hematology & Oncology 2016cited by 152position: firstdoi
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Blood 2016cited by 125position: middledoi
Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
Oncotarget 2016cited by 113position: middledoi
An epigenomic approach to therapy for tamoxifen-resistant breast cancer
Cell Research 2014cited by 188position: middledoi
GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex
Proceedings of the National Academy of Sciences 2014cited by 128position: middledoi
Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia
Leukemia 2014cited by 45position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2019–2025)Xin Li · Baylor College of Medicine5 papers (2023–2025)Fangrui Wu · Nanjing Tech University3 papers (2016–2020)Qin Feng · Shanxi Medical University2 papers (2014–2020)Jingyu Wu · Fujian Medical University2 papers (2016–2019)Tong Huo · Baylor College of Medicine2 papers (2019–2020)Xuejun Xu · Nanjing University of Chinese Medicine1 papers (2016–2016)Lijia Chen · Shanghai Medical College of Fudan University1 papers (2020–2020)Yunyun Chen · Sun Yat-sen University1 papers (2016–2016)Bin He · Zhejiang International Studies University1 papers (2020–2020)Hong Kim · New York University1 papers (2020–2020)Allison B. Rosen · Baylor College of Medicine1 papers (2016–2016) · 1 papers (2014–2014)Zhen Tang · Southwestern Medical Center1 papers (2020–2020)Scott R. Daigle · EduInnovation1 papers (2016–2016)James E. Bradner · Novartis (China)1 papers (2014–2014)Yuanda Hua · The University of Texas at Arlington1 papers (2019–2019)Xiaowei Wu · Clarivate PLC1 papers (2020–2020)Bala Krishna Moku · Baylor College of Medicine1 papers (2023–2023)Md Ashraf-Uz-Zaman · Baylor College of Medicine1 papers (2024–2024)